# Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion

Study · id `cardio:ct-nct07668323` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07668323](<https://clinicaltrials.gov/study/NCT07668323>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07668323

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 372 participants.

## Technical summary

Registry record NCT07668323. Randomized; single masking; primary purpose treatment. Start 2026-09-19 (actual); primary completion 2029-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 372 participants (planned count; ClinicalTrials.gov record NCT07668323, source copy `cardio:ctgov-nct07668323-2026-09-23`, retrieved 2026-10-26)
- Started: 2026-09-19 (actual) (ClinicalTrials.gov record NCT07668323, source copy `cardio:ctgov-nct07668323-2026-09-23`, retrieved 2026-10-26)
- Primary completion: 2029-01-31 (anticipated) (ClinicalTrials.gov record NCT07668323, source copy `cardio:ctgov-nct07668323-2026-09-23`, retrieved 2026-10-26)
- Completion: 2029-05-31 (anticipated) (ClinicalTrials.gov record NCT07668323, source copy `cardio:ctgov-nct07668323-2026-09-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07668323, source copy `cardio:ctgov-nct07668323-2026-09-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07668323-2026-09-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
- Acronym: IAT-MEVO
- Condition: Medium Vessel Occlusion
- Condition: Ischemic Stroke, Acute
- Intervention (Drug): Recombinant Tissue Plasminogen Activator (rt-PA)
- Intervention (Procedure): Intra-arterial Thrombolysis
- Intervention (Drug): Best Medical Management
- Intervention (Procedure): Rescue therapy
- Lead sponsor: The First Affiliated Hospital with Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital with Nanjing Medical University (`cardio:org-the-first-affiliated-hospital-with-nanjing-medical-898271`)

## Provenance

Content hash: 121c782009182ae2e477b0eda95b99202101db73e936d63bcb501e13177eedbc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
